Literature DB >> 8081761

Donor heart endothelial cells as targets for graft infiltrating lymphocytes after clinical cardiac transplantation.

N H Jutte1, P Heijse, M H van Batenburg, L M Vaessen, B Mochtar, A H Balk, F H Claas, W Weimar.   

Abstract

The in vitro cytotoxic reactivity of allograft infiltrating cells cultured from endomyocardial biopsies was tested against endothelial cells (EC) isolated from the own donor heart. EC derived from pieces of atrium were found to be proper targets for graft infiltrating cytotoxic T cells from four patients. The specificity of this cytotoxicity was further analysed by cold target inhibition studies and blocking with anti-CD3, anti-CD4 or anti-CD8 monoclonal antibodies. The experiments revealed that, besides a clearly HLA directed recognition, a more heterogeneous, multispecific response can be found, which might be partially explained by the activity of EC specific T cell clones. We conclude that this system provides a valuable approach to investigate the reactivity of graft infiltrating cells against EC in relation to the clinical course of the transplantation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8081761     DOI: 10.1016/0966-3274(93)90057-f

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  3 in total

1.  The development of transplant coronary artery disease after cardiac transplantation is correlated with a predominance of CD8+ T lymphocytes in endomyocardial biopsy derived T cell cultures.

Authors:  N H Jutte; K Groeneveld; A H Balk; A J Ouwehand; E H Loonen; M Van der Linden; S Strikwerda; B Mochtar; F H Claas; W Weimar
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

Review 2.  Immune-mediated vascular injury and dysfunction in transplant arteriosclerosis.

Authors:  Anna von Rossum; Ismail Laher; Jonathan C Choy
Journal:  Front Immunol       Date:  2015-01-12       Impact factor: 7.561

Review 3.  Alloreactivity of virus-specific T cells: possible implication of graft-versus-host disease and graft-versus-leukemia effects.

Authors:  Shigeo Fuji; Markus Kapp; Hermann Einsele
Journal:  Front Immunol       Date:  2013-10-14       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.